Unichem Group Launches "All Together Now" Legacy Documentary in the UK

In a filmic experience that touched the hearts of many throughout the nation, healthcare innovators Unichem Group, in partnership with Luex Healthcare UK, launched their acclaimed documentary,“A"Come Together Now," for public awareness.

In a realm where heritages are frequently passed down,thisone that was achieved amidst challenges, dedication, and the unspoken resilience of a family that would not collapse.

At the heart of the narrative is Dr. H.D. Mohan, a person who left school at 12 and was uprooted during the Partition of Sindh in 1947, an event that marked one of the most harrowing mass movements in recent history.

Numerous Sindhi Hindus, like him, left their native land during a period of turmoil and bloodshed, ultimately discovering safety and direction in Africa.

Dr. Mohan traveled to Liberia in West Africa, where he reestablished his life and established a successful pharmaceutical company. He didn't merely sell medications; he became the reliable link between West Africa and major global companies such as Pfizer and Boots, assisting in introducing international standards and life-saving products to new areas. For Dr. Mohan, this was not just a business venture, but a mission: to heal with respect, to serve with modesty, and to lead with passion.

But in 1989, Liberia was engulfed by civil war. The business was lost. Once more, everything was destroyed. Records were gone, assets wiped out, twice uprooted, twice left with nothing, yet he started over. This time, in Ghana, not with resentment, but withboundless humility. Not to gain riches, but to regain wellness.

With him during the company's most critical years was his son, Sir Raj Mohan, currently serving as the Executive Chairman of Unichem Group.

A powerful yet subtle figure, Sir Raj, during the civil unrest in Liberia, played a key role in rebuilding the company from scratch in Ghana in 1992, bringing with it a stronger spiritual dimension.

He has brought spiritual depth, ethical clarity, and a sense of purpose across generations to the company. With his leadership, Unichem evolved from a family-owned business into a true business family. And it is by his consistent guidance that the company now has a presence throughout the continent.

Extending this vision around the world is Sunil Mohan, CEO of Luex Healthcare UK, whose international leadership has turned the Luex name into a representation of medical reliability and moral affordability.

In the past 30 years, with Mr. Sunil at the helm, Luex's main products have become essential in Africa, such as: Luex Cough Syrup – Preferred by more than 100 million individuals over the last 20 years.

Other options include Mycolex – an antifungal treatment endorsed by the Dermatology Society, and Metrolex-F – a reliable therapy for infectious diarrhea, known for saving millions of lives.

Backing the larger vision is Vishaal Mohan, the oldest of the Mohan brothers. Mr. Vishaal serves as CEO of Unichem Ghana, and his strategic guidance keeps steering the company's direction with honesty as he leads one of the most energetic and capable pharmaceutical marketing teams in the region.

Among the leading figures is Jason Nana Yaw Mohan, CEO of Unichem Industries, who is a well-known and influential presence in the nation's healthcare sector. With his charm, humility, and strong dedication to building a lasting impact, Jason has been instrumental in keeping the Unichem narrative closely tied to the communities it supports, not only through pharmacies but also within local areas and worldwide.

In addition to its filmic excellence, the documentary stands as an archival achievement and includes more than 50 perspectives from various sectors within the healthcare field:

From pharmacists to decision-makers, physicians to suppliers, government representatives to local collaborators, each provides a perspective on the human essence within the brand.

Among the numerous strong acknowledgments: Dr. Bernard Toboh, prominent urologist:They have established themselves as a pioneer in unyielding Quality Healthcare.”

Presented by Natalie Fort, the opening screenings highlighted that Unichem is more than just a pharmaceutical company. It is a dynamic narrative, reflecting perseverance, transformation, and innovative leadership.

And it serves as a reminder that certain legacies are not passed down — they are gained, each and every day.

Read More

Bajaj Finance Unveils 'Loan Utsav' for Doctors with Up to Rs. 5,000 Cashback

NewsVoir

Pune (Maharashtra), India, July 18: Bajaj Finance has introduced a time-bound promotion for healthcare workers as part of its continuous 'Loan Utsav' initiative. This deal aims to assist physicians in addressing their financial requirements related to their profession—such as enhancing diagnostic equipment, growing a practice, or handling daily administrative tasks.

The initiative offers healthcare workers the opportunity to access adoctor loanA cashback of up to Rs. 5,000 is available for a loan amount of up to Rs. 80 lakh during the offer period. This benefit gets added to the user's Bajaj Pay Wallet once the loan is successfully disbursed.

The promotion is valid between July 1 and July 31, 2025, and is available to the first 50 doctors who finish their application and loan process via the Bajaj Finserv App or website and set up a Bajaj Pay Wallet within the campaign timeframe.

Key features and qualification requirements

During this short-term 'Loan Utsav' initiative, healthcare practitioners can not only obtain the financial support required to enhance their current practice, but also gain extra financial incentives.

Here are the main points of this initiative that will assist physicians in gaining a clearer insight into what the offer includes and how they can take advantage of it:

* Loan amount: Medical professionals can access business loans of up to Rs. 80 lakh

* Cashbackbenefit: Up to Rs. 5,000 added to the Bajaj Pay Wallet once the loan is successfully disbursed

* Promotion duration: From July 1 to July 31, 2025, or until the first 50 loans are successfully issued

* Eligibility: Accessible to physicians who apply via the Bajaj Finserv App or website throughout the promotion period

* First-come, first-servedOnly the initial 50 loans that have been issued are eligible for the cashback.

Cashback reward structure

Here's the amount of cashback a healthcare professional can receive following successful loan disbursement during the 'Loan Utsav' initiative:

CashbackThe customer's Bajaj Pay Wallet is credited after the loan is successfully disbursed. If a customer does not have an active Bajaj Pay Wallet, rewards will be provided in the form of Bajaj Coins, which can be redeemed through the Bajaj Finserv App.

How to access the offer

These are the procedures to be adhered to in order to claim the promotion:

* Access the Bajaj Finserv app or website, go to 'Doctor Loan', and select 'Check'Eligibility' button

* Complete the application form by providing essential information such as full name, PAN, date of birth, and medical registration certificate.

* Once you have filled in all the necessary details, select 'Continue' to proceed to the loan options page.

* Define the loan amount required and select among our three physician loan choices: Term Loan, Flexi Term Loan, or Flexi Hybrid Term Loan.

* Choose your desired loan term, which can be between 12 and 96 months, and then click 'Continue'.

* Finish the banking procedure and submit the physician loan application.

What makes Bajaj Finserv Doctor Loan a good choice?

Bajaj Finserv Doctor Loan offers a range of benefits that make it a great option. Below are some important advantages of choosing this loan:

1. Large loan amount: Doctors and healthcare professionals can access a loan of up to Rs. 80 lakh, which can be utilized for significant purchases of medical devices, expansion of clinics, or covering day-to-day expenses.

2. Variable loan term: The repayment period varies between 12 months and 96 months, allowing it to match the borrower's financial circumstances.

3. Attractive interest rates: The loan offers cost-effectivedoctor loan interest rates, which makes it affordable and simple to pay back.

4. Fast release of funds: Through minimal documentation and straightforward procedures, the loan is typically released within 48 hours*, allowing medical practitioners to obtain financial support promptly.

5. No security required: This loan designed for medical professionals is unsecured, so there's no necessity to offer any collateral to access it.

Under the Loan Utsav promotional offer, medical professionals can now access premium financial solutions along with extra benefits. Apply for the Bajaj Finserv Doctor Loan today to get funding as high as Rs. 80 lakh and receive a cashback of up to Rs. 5,000.

*Terms and conditions apply.

Bajaj Finance Ltd. ('BFL', 'Bajaj Finance', or 'the Company'), a division of Bajaj Finserv Ltd., is a deposit-taking Non-Banking Financial Company (NBFC-D) that is registered with the Reserve Bank of India (RBI) and categorized as an NBFC-Investment and Credit Company (NBFC-ICC). BFL operates in the lending and deposit acceptance sectors. It maintains a varied lending portfolio covering retail, small and medium enterprises (SMEs), and commercial clients, with a strong presence in both urban and rural areas of India. The company accepts public and corporate deposits and provides a wide range of financial services to its customers. As a business that has been around for thirty-five years, BFL has emerged as a major player in India's NBFC industry, boasting a total customer base of 69.14 million on a consolidated level. BFL holds the top domestic credit rating of AAA/Stable for long-term borrowing, A1+ for short-term borrowing, and CRISIL AAA/Stable & [ICRA]AAA(Stable) for its fixed deposit program. Additionally, it has a long-term issuer credit rating of BB+/Positive and a short-term rating of B from S&P Global ratings.

To know more, visit www.bajajfinserv.in

(ADVERTORIAL DISCLAIMER: The aforementioned press release has been submitted byNewsVoir. ANI will not be held responsible in any manner for the content thereof)

Read More

Godrej Hosts Global Healthy Workplace Summit and Awards

PRNewswire

Mumbai (Maharashtra) [India], July 18: The Godrej Industries Group has joined forces with The Global Centre for Healthy Workplaces (GCHW) and Arogya World to organize a two-day Global Healthy Workplace Summit & Awards event at Godrej One, Mumbai, aiming to tackle the increasing challenges faced by India and the global community.healthcare challenges. Collaborates with The Global Centre for Healthy Workplaces and Arogya World to organize the Global Healthy Workplace Summit & Awards. This prestigious event aims to stimulate discussions on emerging benchmarks in workplace wellness and honor top organizations from India and globally for their ongoing commitment to employee health and wellbeing. The Global Healthy Workplace Summit & Awards is set to take place on November 20 and 21, 2025.

The International Healthy Workplace Summit & Awards will be held in India for the first time on November 20-21, 2025, and will gather global leaders,healthcare experts, industry bodies, policymakersand organizations to discover innovative approaches for enhancing employee health and happiness. The event is being organized in collaboration with the Global Centre for Healthy Workplaces and Arogya World, a nonprofit gaining widespread recognition as a key player in workplace health in India. Building upon insights from earlier Arogya World conferences in India, including topics like shaping the future of work, incorporating artificial intelligence into workplace wellness, and aligning ESG (Environmental, Social, and Governance) objectives with health-focused initiatives, this year's summit seeks to establish new global benchmarks in workplace wellness. The event will highlight India's top companies committed to employee health and well-being and will also unveil the Healthiest Workplaces in the world for 2025.

Focusing heavily on preventing non-communicable diseases (NCDs), providing mental health assistance, and incorporating wellness into company culture, the 2025 Summit will tackle the unique health issues and possibilities across the globe and specifically within the Indian work environment. The event will also highlight proven corporate wellness efforts and effective methods related to Arogya World's MyThali nutrition initiative, Lifestyle Coach training program, and Tobacco-Free Workplace approaches.

Speaking about the chance to host the summit, Ajay Bhatt, Group Head of Corporate Services at Godrej Industries Group, stated, "At Godrej Industries Group, we have consistently emphasized the importance of platforms and interactions that promote health and wellness beyond conventional methods. Collaborating with The Global Centre for Healthy Workplaces and Arogya World aligns with our commitment to fostering healthy work environments. We aim to encourage Corporate India to implement innovative approaches that focus on comprehensive employee well-being and tackle the specific challenges of modern, fast-changing workplaces."

Barry Crisp, the Director of Marketing and Communications at the Global Centre for Healthy Workplaces, stated, "This is a special moment for employee wellness. Organizing our 13th Global Healthy Workplace Awards & Summit in Mumbai, in collaboration with Arogya World and Godrej Industries Group, presents a strong chance to exchange international best practices and promote a health-focused culture. We hold the belief that 'Good Health is Good Business,' and this summit supports our goal of making workplace wellness a worldwide priority in every industry and region."

Ms Srabani Banerjee, Chief of Programs at Arogya World, stated, "Dedicated to comprehensive employee well-being, we at Arogya World assist organizations in adopting a data-focused approach to health by integrating employee wellness into their main business strategies, thus promoting more socially responsible actions. We are thrilled to collaborate with the Global Centre for Healthy Workplaces and Godrej Industries Group, and bring this conversation to the global spotlight."

These lively partnerships will provide an energetic space for exchanging effective methods, gaining insight into new developments, and promoting impactful projects within work environments covering health policies and procedures.

About Godrej Industries Group:

The Godrej Industries Group (GIG) reaches 1.1 billion consumers worldwide, operating in various sectors such as consumer goods, real estate, agriculture, financial services, and chemicals. Godrej was established in 1897 with the aim of supporting India's economic self-reliance. We are dedicated to advancing and enhancing this tradition of innovation for a purpose, creating a more sustainable future, while considering both the environment and people along with profits.

GIG encompasses a range of quickly expanding enterprises that are top contenders in their specific fields. Godrej Consumer Products (GCPL) is a rising FMCG leader in emerging markets, specializing in Home and Personal Care, with an increasing footprint across Asia, Africa, and Latin America. Godrej Properties (GPL) stands as India's premier real estate developer in terms of sales, applying the Godrej principles of creativity, environmental responsibility, and quality within the real estate sector. Godrej Agrovet (GAVL) offers a variety of businesses that tackle major issues confronting Indian agriculture, enhancing the efficiency of Indian farmers through innovative products and services that sustainably boost crop and animal production. Godrej Industries (Chemicals), the group's oldest venture, is India's top producer of oleochemicals and surfactants. Godrej Fund Management (GFM) serves as the real estate private equity division of the group. Godrej Capital (GC), the most recent addition to the group, is a rapidly expanding financial services company.

For further details about the Company, please visit the website.www.godrejindustries.com

About Arogya World:

At Arogya World, we promote a powerful, on-site health approach that provides preventive care in the places where people reside, study, and are employed. By integrating scientific accuracy with widespread implementation, our impactful programs make preventive health available, tailored, and easy to act upon. Our main objective is preventing non-communicable diseases, including Type 2 diabetes, heart disease, cancer, and chronic respiratory illnesses, which are placing a heavy burden on India's healthcare system.

We have already connected with 19 million individuals by 2024. Maintaining strong momentum, we are positioned to achieve 50 million in the following 3-5 years, demonstrating that prevention efforts can be both extensive and long-lasting.

For further details about our initiatives, kindly visit our website.www.arogyaworld.org

About the International Center for Healthy Workplaces:

The International Centre for Healthy Workplaces (GCHW) advocates for a coordinated global approach to workplace health, acknowledging that "Good Health is Good Business." Since its establishment in 2012, GCHW has been leading the way in fostering healthier and more efficient work environments through knowledge sharing, acknowledgment, and the adoption of top practices. The organization's goal is to assist employers and employees across all sizes and industries in attaining sustainable and fair health results. In the last ten years, GCHW has organized 12 Global Summits in nine different countries, held regional workshops and international discussions, and managed the renowned Global Healthy Workplace Awards. With over 370 applications for awards from six continents and 25 companies receiving global certification, GCHW remains at the forefront of promoting innovation, adaptability, and cooperation in workplace wellness on a global scale.

For further details, kindly visitwww.globalhealthyworkplace.org

Logo: https://mma.prnewswire.com/media/2561817/5421109/Godrej_Industries_Group_Logo.jpg

(ADVERTORIAL DISCLAIMER: The above press release has been provided byPRNewswire. ANI will not be held responsible in any manner for the content thereof)

Read More

Essential Health Reforms Must Be Non-Negotiable

NIGERIA, the most populated nation in Africa, still faces difficulties with its public health system, which has been dealing with long-standing and complicated issues. Hence, it is essential to ensure every citizen has access to high-quality medical care, and establishing confidence in healthcare institutions has now become a critical national focus.

On June 30, Health and Social Welfare Minister Mohammed Pate revealed during a meeting of the Ministerial Oversight Committee in Abuja that the federal government's tax reform will enhance health financing. He mentioned that the recent tax law enacted by President Bola Tinubu will raise government revenue, which will subsequently support essential services such as healthcare. These kinds of assurances are not unprecedented.

Nigeria has depended significantly on outside financial support for its health initiatives, but the government is now committed to altering this situation. Well said.

Interestingly, Nigerians, particularly the elite, allocate between $1.1 billion and $2 billion each year for medical travel. This drains the economy.

As part of this initiative, Pate revealed the intended distribution of N32 billion, approximately N140 per person, over a six-month period to enhance access to high-quality healthcare across the country.

This distribution, which is not sufficient and applies to the timeframe from April through June 2025, is expected to be made available by the end of August.

However, although this influx of money is a beneficial move, it does not fully tackle the underlying, structural problems affecting the healthcare system.

Ongoing insufficient funding has resulted in hospitals being poorly equipped, facing shortages of critical medications, and lacking proper infrastructure. The share of the budget dedicated to the health sector since 2001, when Nigeria set a goal of 15 percent, shows that the nation has repeatedly fallen short of realizing the goal of Universal Health Coverage.

A significant lack of healthcare workers exists. Numerous physicians and nurses keep looking for improved prospects overseas because of unfavorable working environments and minimal compensation. As per a study, more than 16,000 doctors are said to have left in the past five to seven years.

Although rural regions face challenges in accessing healthcare services, numerous urban areas deal with hospitals that are short-staffed, partially because of long-standing corruption that has turned internship positions for medical students into a financial opportunity, thereby preventing many skilled medical personnel from entering the system.

The industry faces challenges including poor policy enforcement, disjointed health insurance systems, and instability, resulting in millions of people lacking essential care and having restricted access to healthcare services.

Approximately 20 percent of the more than 30,000 Primary Health Centres spread throughout Nigeria are completely operational. The remaining ones are unable to deliver fundamental primary healthcare services, as reported by the National Primary Health Care Development Agency.

Regrettably, the systematic casualization of medical staff, which was initially meant to be a temporary solution for staffing shortages, has turned into a dilemma for numerous doctors whose pay is considerably less than that of their full-time counterparts, despite carrying out the same responsibilities.

Temporary medical staffing, often referred to as locum work, was implemented by the government to swiftly address personnel shortages in hospitals, particularly when administrative processes caused delays in official hiring under the federal service system.

Medical professionals working under temporary agreements, some of which are renewed on a monthly or quarterly basis, are not eligible for regular benefits, such as pension contributions, health coverage, paid time off (including maternity and paternity leave), residency or advanced training opportunities, risk and on-call allowances, and chances for career advancement or official acknowledgment.

These difficulties demand a planned and comprehensive strategy. Nigeria needs to focus on healthcare, boost financial resources, enhance salaries and overall conditions for medical personnel.

The Nigerian administration must create a temporary staffing policy that will outline the procedures for hiring, overseeing, compensating healthcare workers, and guaranteeing prompt and equitable payment.

PHCs need to be improved, supplied with necessary resources, and have sufficient personnel. There must be enough financial support for medical services, and people should be able to obtain health coverage.

Successful healthcare reforms can decrease the impact of illnesses, reduce death rates, and enable more Nigerians—no matter their income level or geographic location—to obtain the medical care needed for improved health and greater productivity.

Provided by SyndiGate Media Inc. (Syndigate.info).

Read More

150+ Pharma Firms Registered in Nigeria — ACPN

The Association of Community Pharmacists of Nigeria (ACPN) has revealed that Nigeria currently has more than 150 licensed pharmaceutical manufacturers, with at least five of them accredited by the World Health Organization (WHO) for Good Manufacturing Practice (GMP), marking a significant achievement that highlights the sector's increasing capabilities amid ongoing obstacles.

This information was disclosed before the organization's 44th National Conference, which is set to take place in Awka, Anambra State, from July 22 to 27, 2025.

During a pre-conference media briefing, the National Chairman of ACPN, Ambrose Ezeh, told journalists that the pharmaceutical industry is steadily progressing towards becoming a multi-billion-dollar sector.

"Never doubt it, the pharmaceutical industry keeps expanding despite all challenges," Pharm. Local manufacturers, including well-known Nigerian investors, are constructing Active Pharmaceutical Ingredient (API) facilities with investments reaching tens of millions of dollars.

These initiatives are transforming the framework of the game and contributing to the establishment of pharmaceutical security in Nigeria.

He provided examples of major pharmaceutical companies, including Fidson Healthcare, which has been significantly involved in the manufacture of anti-retroviral medications, Emzor Pharmaceuticals, which recently established a Cephalosporin facility, and Jawa Pharmaceuticals, an Indian firm that has introduced a beta-lactam production unit in Nigeria.

As per Ezeh, due to recent funding and planned growth initiatives, the sector is expected to increase from its present estimated worth of $2 billion to up to $10 billion within the next five years.

The ACPN also praised Codix Healthcare for setting up a local facility to produce in-vitro diagnostic kits and medical supplies, enhancing the nation's ability to be self-sufficient in critical health products.

He mentioned that although there have been improvements, the association pointed out that the industry still needs intentional assistance from the government.

We call on the government at every level to assist pharmaceutical producers by offering specific incentives, such as access to equipment and raw materials that comply with GMP requirements.

"Local production offers significant potential for generating employment, fostering economic development, enhancing international trade, and strengthening national security," Ezeh stated.

He cautioned that poorly executed policies, like the contentious MEDIPOOL initiative, might hinder advancement if those involved, such as pharmacists, are not adequately included in discussions.

"Policies should not be created independently. The Federal Ministry of Health needs to engage more with stakeholders involved in pharmacy practice prior to implementing changes," he added.

The ACPN also urged the government to revise the Fake Drug Act to impose harsher consequences for violators and to completely enforce the National Drug Distribution Guidelines (2015), designed to clean up Nigeria's disordered pharmaceutical supply network.

Shifting focus to professional politics within the health sector, Pharm. Ezeh voiced his frustration regarding what he referred to as "the ongoing subordination of pharmacists and other healthcare professionals by physicians," whom he blamed for shaping policies in their own interest.

He stated: "The government keeps favoring doctors who desire that every title, position, or benefit in the healthcare sector be reserved solely for members of the Nigerian Medical Association (NMA)."

This challenges the independent judgment of other skilled healthcare practitioners.

Ezeh also raised the question of why only doctors are selected as Chief Executive Officers of federal health institutions, and expressed concern that even though a consultant level for pharmacists was introduced in 2015, many hospitals continue to refuse to adopt it.

We, as a profession, have invested millions in training for the fellowship program that paves the way to becoming a consultant, but we face obstacles at every stage," he stated. "Ironically, doctors who get government-sponsored training frequently leave the country, while pharmacists who finance their education themselves are blocked from career advancement.

The group also took a strong position against the proposed National Health Facility Regulatory Authority (NHFRA) Bill that is currently under consideration by the National Assembly, cautioning against any effort to combine the Pharmacy Council of Nigeria (PCN) with other regulatory agencies.

It is one of the factors that enabled Nigeria to reach WHO Maturity Level 3 in medicine regulation. A merger would reduce our efficiency and disrupt years of advancement.

He mentioned that international best practices in nations such as the United States, the United Kingdom, Canada, and South Africa involve having independent pharmacy councils to ensure professional standards and public safety.

With the Awka conference approaching, the ACPN reaffirmed its dedication to reforms aimed at guaranteeing the availability, access, and affordability of safe and high-quality medicines in Nigeria.

The vision is distinct," Ezeh stated. "We will continue to advance, as the scripture mentions, 'I, the Lord, bring down the tall tree and cause the low tree to grow tall, I have spoken and I will accomplish it'.

Provided by SyndiGate Media Inc. (Syndigate.info).

Read More

CarePal Co-Founder Piyush Jain Honored with 2025 Harvard Innovation Award

NewsVoirMumbai (Maharashtra) [India], July 10: Piyush Jain, Co-Founder and CEO of CarePal Group and Impact Guru, has received the 2025 Alumni Innovation Award from the Harvard Kennedy School (HKS) Alumni Board at Harvard University. Piyush, who graduated from the 2013 Master's in Public Policy Program at HKS, was selected from a strong competition for his significant contributions to healthcare financing in India. Over the past ten years, Impact Guru, which was nurtured at the Harvard Innovation Labs, has already assisted more than 50,000 patients and involved 4.5 million donors worldwide, making Piyush a leader who has effectively applied technology-based innovation to create broad social impact by addressing complex issues in healthcare. The Award honors HKS alumni who exhibit outstanding leadership, ingenuity, and commitment to bringing about positive change for individuals and communities through technology. In addition to his work at Impact Guru, Piyush has also co-founded CarePal Money - a healthcare lending platform and CarePal Secure - a health protection and insurance marketplace. CarePal Money provides zero-interest healthcare loans in India and has already helped over 1,200 patients within 18 months to access non-critical treatments without financial burden by collaborating with healthcare providers and lending institutions. CarePal Secure offers innovative health benefits and insurance plans for more than 200,000 customers, addressing vital gaps for India's underinsured middle class and lower-income population. Piyush was recognized with the award on Friday, May 16, 2025, at the Harvard Kennedy School during the Forum as part of the alumni reunion weekend.

Piyush Jain, Co-founder and CEO of CarePal Group, stated, "I am deeply honored to have received the Alumni Innovation Award from Harvard Kennedy School. This recognition is particularly meaningful to me because ImpactGuru (and CarePal) was initially conceived during my time as a student as part of a PAE (Policy Analysis Exercise) project and was nurtured at the Harvard Innovation Lab. What started as an academic endeavor has evolved into a real-world mission - to make healthcare more affordable and accessible for millions of families in India and beyond. I sincerely appreciate the faculty, classmates, and the HKS and Harvard community that supported bold ideas and purpose-driven entrepreneurship. I feel privileged to share this remarkable honor with my co-founders, committed team members, supportive investors, empathetic hospital partners and doctors, courageous patients and their families, generous donors, and all our insurance and lending partners who have consistently believed in our mission. We are dedicated to working diligently on our mission to ensure that no one dies due to a lack of funds for healthcare in India and to positively support the healthcare financing needs of over 1 million customers by 2030." Other award recipients at Harvard this year included Natalia Gavrilita, former Prime Minister of Moldova, who received the Alumni Public Service Award. At the same time, Sebastian Burduja, Romania's Minister of Energy, was awarded the Emerging Global Leader Award. Carol Finney, Director of Harvard University's MPA/ID Program, received the Julius E. Babbitt Memorial Volunteer Award, and Lisa B. Sloane was recognized with the HKS Fund Outstanding Alumni Award. CarePal is an integratedhealthcare financeA system that integrates a medical lending marketplace (CarePal Money), insurance and protection services (CarePal Secure), and a crowdfunding platform (Impact Guru) for healthcare funding. Our goal is to ensure that essential and elective treatments are accessible and affordable for all households in India. (ADVERTORIAL DISCLAIMER: The following press release has been provided byNewsVoir. ANI will not be held responsible in any manner for the content thereof)

Read More

The hidden health signals your nose can uncover

Several of us throw away that tissue without a moment's consideration.

However, experts now claim that the color of mucus exiting your nose might indicate concealed signals regarding your well-being.

The human body produces approximately 100 milliliters of mucus daily — which is about 6.5 tablespoons — most of which is swallowed into the stomach, though some also comes out through the nose.

Medical professionals have conducted extensive research on mucus, often referred to as snot, categorizing it into seven different colors. These color variations can provide insights into whether an individual is suffering from an infection, an allergic reaction, or if they are inhaling excessive amounts of polluted air.

"If your mucus is changing color, you should check for other symptoms," Dr Raj Sindwani, an ear, nose, and throat specialist at theCleveland Clinic said.

It's the concept that you were managing well, nothing was troubling you, and then something shifted. You'll need to [consider] what other changes might have occurred.

In general, specialists mentioned that mucus should be transparent in color — showing that all systems are working properly.

However, if this occurrence changes or the mucus becomes more abundant, it might suggest an underlying issue.

Mucus within the nasal passages plays a crucial role in maintaining open airways by capturing dust particles and harmful microorganisms, enabling normal breathing.

It also strengthens the immune system, as the mucus contains antibodies capable of fighting off harmful invaders, and it moistens the air inhaled, helping to keep the airways from becoming dry and irritated.

Among the colors to watch for, medical professionals indicate that white, cream-like, or pale yellow mucus indicates the body is battling a cold or another viral illness, as the white hue results from white blood cells working to eliminate invading pathogens.

When mucus thickens and takes on a yellowish-green color, it indicates that the body is combating a bacterial infection or inflammation in the nasal passages.

Reddish or pink mucus could suggest that a tiny blood vessel in the nasal passage ruptured at some point, and the blood has since dried up.

In addition, mucus that is brown in color may also suggest overexposure to air contaminants or heavy cigarette use, whereas black mucus could mean the body is battling a severe fungal infection.

Experts also suggest that the quantity of mucus generated in the nose might serve as an indicator of an underlying issue.

If an individual's nose generates a significant amount of mucus, this might signal a bacterial infection or an allergic response to pollen - which can lead to increased mucus production in the nasal passages.

In some rare instances, specialists suggest it could also indicate an early symptom of Parkinson's disease.

One of the earliest indicators that individuals with Parkinson's disease experience is difficulty using the muscles in their nose and throat, leading to the buildup of saliva and mucus in their nasal passages, as stated by the Parkinson's Foundation.

Examining an individual's mucus could also provide clues about Alzheimer's disease.

Studies have also found that high levels of amyloid proteins in nasal mucus could suggest that an individual is experiencing Alzheimer's disease.

It is thought that Alzheimer's disease results from the formation of amyloid plaques and tau tangles in the brain, which lead to cell damage and death.

Amyloid protein molecules aggregate within brain cells, creating clusters known as plaques. Meanwhile, tau proteins intertwine into thread-like structures referred to as tangles.

The plaques and tangles hinder the brain's neurons from transmitting electrical and chemical signals between each other.

Gradually, this disturbance results in lasting harm to the brain, which contributes to the development of Alzheimer's disease.

Although it is still unknown how and when the amount of amyloid proteins rises in the nasal secretions of individuals, research has indicated that the detection of these proteins in nasal mucus serves as a distinct indicator for Alzheimer's disease in the brain.

Consequently, researchers point out that analyzing nasal secretions at an early stage to identify specific proteins may aid in delaying the disease's advancement by initiating therapies sooner.

Furthermore, recent studies suggest that analyzing the sticky fluid could also reveal if an individual is prone to developing chronic obstructive pulmonary disease (COPD) – an inflammatory lung condition and the sixth most common cause of death in the United States.

A July 2025 study A study published in the Journal of Allergy and Clinical Immunology revealed that individuals who smoked for many years and had elevated levels of a protein known as IL-26 in their mucus were more prone to developing COPD.

Swedish scientists discovered that elevated amounts of the protein in the lungs and mucus of individuals who smoke indicated reduced lung function and limited respiratory capacity.

Read more

Read More